Registered Workshop Attendees

Terry Adirim

Department of Homeland Security

Will Alameida

PanThera Biopharma

Jennifer Alton

Bavarian Nordic

Margaret Anderson


Lida Anestidou

The National Academies

Marietta Anthony

Critical Path Institute

Stacy Arnesen

National Library of Medicine/National Institutes of Health

Damon Arnold

Illinois Department of Health

Phyllis Arthur

Biotechnology Industry Organization, Inc.

Bruce Artim

Eli Lilly and Company

Guillermo Aviles-Mendoza


Sheila Avruch

Government Accountability Office

Gerrit Bakker


Tali Bar-Shalom

Government Accountability Office

Cindy Bascetta

Government Accountability Office

Alison L. Bawden

Soligenix, Inc.

Ketty Belizaire

TB Alliance

Georges Benjamin

American Public Health Association

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 79
C Registered Workshop Attendees Terry Adirim Bruce Artim Department of Homeland Security Eli Lilly and Company Will Alameida Guillermo Aviles-Mendoza PanThera Biopharma HHS/ASPR Jennifer Alton Sheila Avruch Bavarian Nordic Government Accountability Office Margaret Anderson Gerrit Bakker FasterCures ASTHO Lida Anestidou Tali Bar-Shalom The National Academies Government Accountability Office Marietta Anthony Cindy Bascetta Critical Path Institute Government Accountability Office Stacy Arnesen Alison L. Bawden National Library of Soligenix, Inc. Medicine/National Institutes of Health Ketty Belizaire TB Alliance Damon Arnold Illinois Department of Health Georges Benjamin American Public Health Association Phyllis Arthur Biotechnology Industry Organization, Inc. 79

OCR for page 79
80 EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE Kavita Berger Stephen V. Cantrill AAAS Center for Science, National Biodefense Science Board Technology and Security Policy Roberta Carlin Kathleen Berst American Association on Health CBMS-JVAP and Disability Gregory Bice Gail Cassell ASDHA/FHP&R/DoD Eli Lilly and Company Gary Bignami Stacey Chambers PanThera Biopharma, LLC HHS/NIH/NINDS Peter Blain D. W. Chen Health Protection Agency, UK Department of Defense James Blumenstock Kelly Childress Association of State and Territorial Foley Hoag, LLP Officials Kenneth Cole Douglas Boenning ODATSD (CBD/CD)/DoD HHS Susan Coller-Monarez Brent Bomer DHS XOMA Chris Colwell Luciana Borio Becton Dickinson FDA Doug Compton Katie Brewer PhRMA American Nurses Association Francesca Cook Robert N. Brey PharmAthene Soligenix, Inc. Mark Cooke Kathryn Brinsfield PharmAthene Department of Homeland Security Susan Cooper Steve Brozak Tennessee Department of Health StormBio Inc. Brian Corrigan Greg Burel Astellas Pharma US, Inc. Centers for Disease Control and Prevention/OPHPR

OCR for page 79
APPENDIX C 81 Allan Coukell David Evans The Pew Charitable Trusts U.S. Army Medical Research & Materiel Command Brooke Courtney Center for Biosecurity Daniel Fagbuyi Children’s National Medical Center Dack Dalrymple Dalrymple & Associates, LLC Ann Farese University of Maryland Christopher Davis HHS Anthony Fauci NIAID Anne De Groot EpiVax Stuart Feldman Sanofi Pasteur Walla Dempsey HHS/NIH/NIAID Philip Ferro HHS/ASPR Gary Disbrow HHS/BioMedical Advanced Patrick Flavin Research and Development Advanced Life Sciences, Inc. Authority Erin Fowler Jacqueline Dombroski HHS AVI BioPharma, Inc. Thomas Frieden Michael Doney Centers for Disease Control and Centers for Disease Control and Prevention Prevention Chuck Fromer Matthew Duchars Chemical Biological Defense Directorate Lydia Duckworth MITRE/HHS Thomas Fuerst HHS/ASPR Melissa Dupree Fabiani & Company Nick Fullenkamp Emergent BioSolutions Diana Elkis PRTM Claudia Gaffey FDA Peter Emanuel OSTP, White House Alexander Garza Department of Homeland Security

OCR for page 79
82 EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE Bruce Gellin Robert Guidos HHS Infectious Diseases Society of America Jeanne Geyer FDA Elin Gursky ANSER Brent Gibson Atlas Research, LLC James Guyton PRTM Management Consultants David Gilbert Providence Health & Services Jami Haberl Safeguard Iowa Partnership Brett Giroir Texas A&M Jeff Hackman Intercell Lewis Goldfrank New York University School of Nate Hafer Medicine NIH/OD Mark Goldberger Marlene Haffner Abbott Labs Haffner Associates, LLC Michael Goldblatt Veronica Hall Functional Genetics Emergent BioSolutions Phillip Gomez Michael Handrigan PRTM HHS/ASPR Jesse Goodman Julie Hantman FDA HHS/ASPR/BARDA Frank Gottron Maureen Hardwick Congressional Research Service, Alliance for Biosecurity U.S. Library of Congress Chandresh Harjivan John Grabenstein PRTM Merck & Co., Inc. Richard Hatchett Dwayne Grant White House, Executive Office of HHS/OIG the President Gigi Gronvall Herbert Hecht Center for Biosecurity of UPMC Emergent BioSolutions

OCR for page 79
APPENDIX C 83 William Helming James James PRTM Management Consultants American Medical Association D. A. Henderson Paul Jarris Center for Biosecurity of UPMC Association of State and Territorial Health Officials David G. Henry National Governors Association Daniel Jernigan Centers for Disease Control and Jack Herrmann Prevention National Association of County and City Health Officials David Jett NIH/NINDS Penny Hitchcock Tauri Group Kelly Johnson Agency for Healthcare Research Sally Hojvat and Quality OIVD/CDRH/FDA Vicki Johnson Mary Homer National Commission on Children HHS/ASPR and Disasters Omar Hottenstein Jerry Johnston Office of the Assistant Secretary of National Association of Emergency Defense for Health Affairs Medical Technicians Robert House Til Jolly DynPort Vaccine Company, LLC U.S. Department of Homeland Security, Office of Health Affairs Jay Hunter University of Maryland School of Robert Kadlec Medicine PRTM Management Consultants Jean Hu-Primmer Brian Kamoie FDA/Office of Counterterrorism White House, Executive Office of and Emerging Threats the President Patrick Iversen Lisa Kaplowitz AVI Biopharma Alexandria Health Department Rick Jaffe James Kenimer ANSER, Inc., in support of Biologics Consulting Group ODATSD (CBD/CD)

OCR for page 79
84 EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE John Kenten Meso Scale Diagnostics Laura Kwinn HHS Thomas Keuer ARCA biopharma, Inc. Anne Laffoon Government Accountability Office Rima Khabbaz Centers for Disease Control and Randy Larsen Prevention Commission on the Prevention of Weapons of Mass Destruction Lynne Kidder Proliferation and Terrorism Business Executives for National Security Michael Latham Centers for Disease Control and Hye-Joo Kim Prevention Centers for Disease Control and Prevention/Regulatory Affairs Catherine Laughlin DMID, NIAID Lisa Koonin Centers for Disease Control and James Lawler Prevention White House, Executive Office of the President George Korch HHS Matthew Lawlor HHS/ASPR/BARDA Akhila Kosaraju SIGA Theresa Lawrence HHS Nik Koterski U.S. Army Medical Research & Eva Lee Material Command Center for Operations Research in Medicine and HealthCare, Gerald Kovacs School of Industrial and Systems HHS/BioMedical Advanced Engineering, Research and Development Georgia Tech University Authority Janet Leigh Jon Krohmer LSU Health Sciences Center Department of Homeland Security Brad Leissa Michael Kurilla FDA/CDER/OCTEC National Institute of Allergy and Infectious Diseases

OCR for page 79
APPENDIX C 85 Rachel Levinson Brian Lynch Office of the Vice President for BD Medical Research and Economic Affairs, Arizona State University Thomas MacVittie University of Maryland, School of Deborah Levy Medicine Division of Healthcare Quality Promotion, CDC Carmen Maher FDA Thomas Lilburn Bayer Healthcare, LLC Bert Maidment NIH/NIAID Carol Linden HHS/BARDA Michael Mair HHS Alicia Livinski National Library of Medicine, Don Malinowski National Institutes of Health HHS/ASPR/NBSB Staff Cynthia Love Monique Mansoura National Library of Medicine, HHS/ASPR/BARDA National Institutes of Health Maria Marinissen Daniel Lucey HHS/ASPR Georgetown University Medical Center Richard Martin American Society for Radiation Charles Ludlam Oncology Former Counsel, Senator Joseph Lieberman Tyler Martin Former Principal Lobbyist for The Dynavax Technologies Biotechnology Industry Organization James Matthews Sanofi Pasteur Nicole Lurie HHS/ASPR Maritza McIntyre Bavarian Nordic Boris Lushniak FDA Teri Melese UCSF School of Medicine Jayne Lux National Business Group on Health Raina Merchant HHS/ASPR

OCR for page 79
86 EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE Toby Merlin David Noll Centers for Disease Control and Bavarian Nordic Prevention Jeanne Novak Jeremy Middleton CBR International Corp. Elusys Therapeutics Nancy Nurthen Aubrey Miller Chemical Biological Defense FDA Directorate Georgianne Mitchell Michael Ochs City of Baltimore OEM Infectious Diseases Society of America Thomas Monath Kleiner Perkins Caufield & Byers Anthony Oliver NHTSA, Office of Emergency Melinda Moree Medical Services BIO Ventures for Global Health Paul Owens Chanton Morel Lilly Research Laboratories London School of Economics Christopher Ozeroff Carolina Morgan ARCA biopharma, Inc. Government Accountability Office George Painter Erin Mullen Chimerix, Inc. Rx Response Jennifer Pakiam Rick Murray National Institutes of Health American College of Emergency Physicians Peter Palese Mount Sinai School of Medicine, Jomana Musmar New York HHS/ASPR Gerald Parker Padma Natarajan HHS Infectious Diseases Society of America John Parker HHS Thomas Neal MITRE Tracy Parker Department of Homeland Security

OCR for page 79
APPENDIX C 87 Peter Patriarca Resha Putzrath Biologics Consulting Group Navy and Marine Corps Public Health Center Andrew Pavia University of Utah School of Beth Rada Medicine XOMA Raquel Peat Narayani Ramakrishnan FDA/CDRH/OIVD/DMD National Institute of Allergy and Infectious Diseases Mary Pendergast ARCA biopharma, Inc. Jacqueline Rams Southern Research Institute Dana Perkins HHS/ASPR Stephen Redd Centers for Disease Control and David Perryman Prevention Zirus, Inc. Christopher Revere Del Persinger National Commission on Children PhRMA Foundation and Disasters Cheryl Peterson John Rex American Nurses Association AstraZeneca Sally Phillips Andrew Rickles Agency for Healthcare Research HHS/ASPR and Quality David Ridley William Pinard Duke University American Association for the Advancement of Science Corinne M. Ringholz Chemical Biological Defense Douglas Pon Directorate Pfizer, Inc. Rosemary Roberts Elizabeth Posillico Center for Drug Evaluation and Elusys Therapeutics Research, FDA Beena Puri MacKenzie Robertson FDA/CDRH/OIVD/DMD HHS/ASPR

OCR for page 79
88 EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE Robin Robinson Roslyne Schulman HHS American Hospital Association Michelle Rodrigues Talisha Searcy SRI International HHS/OIG Paige Rogers Frederic Selck HHS/ASPR/BARDA Center for Biosecurity Eric Rose Jonathan Shapiro SIGA Technologies, Inc Department of Health and Human Services Philip Russell Sabin Vaccine Institute Jerry Sheehan National Library of Medicine Jerald Sadoff National Institutes of Health AERAS Global TB Vaccine Foundation Marilee Shelton-Davenport National Research Council/ Elizabeth Sadove National Academy of Sciences FDA Angela Shen Ronald Saldarini National Vaccine Program Office, Biological Initiatives HHS Emad Samad Thomas Shipley StormBio Department of Homeland Security Tiffany Sampson Roxanne Shively Department of Homeland Security HHS/ASPR/BARDA Leigh Sawyer David Siegel HHS NIH, NICHD Patrick Scannon Michael Skidmore XOMA Department of Defense Julie Schafer Laura Smart Biomedical Advanced Research Chimerix and Development Authority Brad Smith David Schmickel Center for Biosecurity, UPMC FoxKiser

OCR for page 79
APPENDIX C 89 Frank Sokolik Carmen Tamayo The Joint Commission Foresight Links/FIP Daniel Sosin Janet Tobias Centers for Disease Control and Ikana Media Prevention Eric S. Toner Raul Sotomayor Center for Biosecurity, University HHS/ASPR of Pittsburgh Medical Center Sharon Stanley John Trizzino American Red Cross, National Novavax, Inc. Headquarters Jessica Tucker Craig Steinman HHS Abbott Craig Vanderwagen Tim Stephens HHS/ASPR (retired) National Sheriffs Association Rajeev Venkayya Carolyn Stevens Bill & Melinda Gates Foundation HHS Keith Vesely Tom Stewart Office of the Assistant Secretary of AVI BioPharma Defense for Health Affairs Deborah D. Stine Bruce Walker OSTP Northrop Grumman Corporation Brook Stone Cole Werble HHS/ASPR/NBSB The RPM Report Raymond Strikas Gamunu Wijetunge National Vaccine Program Office, Department of Transportation HHS Ladd Wiley Victoria Sutton Akin Gump Strauss Hauer and Feld Texas Tech University School of Law Andrew Willman National Association of County and Ernie Takafuji City Health Officials National Institute of Allergy and Infectious Diseases

OCR for page 79
90 EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE Theresa Wizemann Debra Yeskey Wizemann Scientific HHS/ASPR/BARDA Communications, LLC Kevin Yeskey April Wood HHS American Red Cross David Yeung Gillian Woollett NIH/NINDS Engel & Novitt, LLP Lauren Yeung Raymond Woosley FDA Critical Path Institute Wesley Yin Casey Wright Boston University HHS/ASPR Yon Yu David Wright Centers for Disease Control and PharmAthene Prevention Justin Wright Stephanie Zaza BD Medical Centers for Disease Control and Prevention David Wurtman NexBio, Inc.